Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

CAPLIPOINT

Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

CAPLIPOINT

Caplin Point Laboratories Ltd. Share Price

2,517.20 -23.50 (-0.92%)
Caplin Point Laboratories manufactures wide range of ointments, creams and other external application preparations in addition to the regular segments of pharmaceutical formulations.
2,510.00Today's Low
2,597.90Today's High
1,500.3052W Low
2,699.0052W High

Fundamentals

Market Cap

₹19,309Cr

EPS

₹84.11

Book Value/Share

₹495.39

P/E Ratio (TTM)

29.02

Industry P/E (TTM)

45.66

P/B Ratio

5.38

Long Term D/E

0.00

ROE

19.92%

Dividend Yield (TTM)

0.30%

Sector P/E Ratio (TTM)

41.98

Sector P/B Ratio

5.79

Analysis

Overview

Key stock indicators that show how well a company is doing, making it easier to understand its true value and performance.

Strong Outperformer

Somewhat Undervalued

Excellent Quality

Low Price Fluctuation

Disclosure and Disclaimer

Shareholding Pattern

Shareholding pattern shows how a company’s shares (ownership) are distributed among different shareholding entities like promoters, Foreign Institutional Investors (FIIs), Domestic Institutional Investors (DIIs), and retail investors, among others. Changes in the shareholding pattern can indicate the performance outlook of a stock.

FAQs on Caplin Point Laboratories Ltd.

The share price of Caplin Point Laboratories Ltd. is ₹2,517.20 on NSE as of 28/8/2026, 8:28:02 pm. Share prices may change frequently due to market movements.

The market capitalisation of Caplin Point Laboratories Ltd. is ₹19,309Cr as of 28/8/2026, 8:28:02 pm

The current Price to Earnings (P/E) ratio of Caplin Point Laboratories Ltd. is 29.03 as of 28/8/2026, 8:28:02 pm

The Price to Book (P/B) ratio of Caplin Point Laboratories Ltd. stands at 5.38 as of 28/8/2026, 8:28:02 pm

Caplin Point Laboratories Ltd. reported an ROE of 19.92% for the last reported financial year on a consolidated account basis.

As of 28/8/2026, 8:28:02 pm, Caplin Point Laboratories Ltd.’s shareholding pattern is: promoters hold 70.60%, FIIs hold 5.80%, DIIs hold 0.40%, and public shareholders hold 21.20%.

The 52-week high of Caplin Point Laboratories Ltd. is ₹2,597.90 and the 52-week low is ₹2,510.00 as of 28/8/2026, 8:28:02 pm.

The earnings per share (EPS) of Caplin Point Laboratories Ltd. is ₹23.27 for the quarter ended Jun 2026.

The stock symbol of Caplin Point Laboratories Ltd. is CAPLIPOINT.

You can buy Caplin Point Laboratories Ltd. shares by opening a demat and trading account with Share.Market and placing a buy order on NSE or BSE during market hours.

The fair value of Caplin Point Laboratories Ltd. depends on factors such as earnings growth, financial performance, and overall market conditions. Investors should assess fundamentals before making investment decisions.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue610.36+1.70%
Other Income33.55+18.30%
Total Income643.91+2.45%
Total Expenditure396.88+0.24%
EBIDT247.03+6.20%
Depreciation21.62+15.00%
Interest0.18-50.00%
Tax46.13+13.73%
Net Profit176.91+4.00%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets2,585.66
Total Non-Current Assets1,459.82
Fixed assets813.59
Total Assets4,045.48
Total Current liabilities385.94
Total Non Current Liabilities28.74
Total Equity Plus Liabilities4,045.48
Total Shareholder Funds3,586.42
Total Debt to Equity0.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity523.23
Cash from Financing Activities-46.46
Cash from Investing Activities-582.29
Net Cash Flow-105.52

Time Period: Daily

SMA/EMA (Moving Average) Analysis

Bullish Moving Averages14

Bearish Moving Averages2

5 Day

2,517.10

10 Day

2,521.90

20 Day

2,540.00

30 Day

2,548.80

50 Day

2,554.50

100 Day

2,239.00

150 Day

2,059.80

200 Day

2,020.10

Indicators

RSI (14)

50.94

MACD (12, 26)

-3.90

MACD Signal Line (9)

1.86

MFI (14)

44.33

ATR (14)

79.84

ADX (14)

18.82

ROC (21)

-2.77

ROC (125)

46.90

Pivot Analysis

Pivot analysis uses a special price point, called the pivot point, to show the overall market trend during different periods. This pivot point is the average of the previous day’s high, low, and closing prices of a specific asset.

TypeR1R2R3PPS1S2S3
Classic2,558.972,577.232,606.372,529.832,511.572,482.432,464.17

Note: Support and Resistance level for the day, calculated based on price range of the previous trading day.

Volume Analysis

Volume analysis tracks how many shares were traded for a specific period. Total traded volume represents the overall number of shares traded, while combined delivery volume indicates only those shares which are delivered (transferred for ownership). Delivered shares indicate long-term investor interest.

Earnings Per Share

Earnings per share (EPS) measures the profit earned by a company for each of its outstanding shares. Generally, the higher a company’s EPS is, the more profitable it is considered to be.

Income Statement

Also called a profit and loss statement, an income statement shows a company’s income, expenses, and how much profit or loss it has made over a specific accounting period. It provides a clear view of how well the business is running.

Particulars (in Cr)Jun 2026Q/Q Change
Operating Revenue610.36+1.70%
Other Income33.55+18.30%
Total Income643.91+2.45%
Total Expenditure396.88+0.24%
EBIDT247.03+6.20%
Depreciation21.62+15.00%
Interest0.18-50.00%
Tax46.13+13.73%
Net Profit176.91+4.00%

Balance Sheet

A balance sheet is a financial statement that details a company’s assets, liabilities, and shareholders’ equity at a given time. It helps assess how financially strong and stable the company is.

Particulars (in Cr)Mar 2026
Total Current Assets2,585.66
Total Non-Current Assets1,459.82
Fixed assets813.59
Total Assets4,045.48
Total Current liabilities385.94
Total Non Current Liabilities28.74
Total Equity Plus Liabilities4,045.48
Total Shareholder Funds3,586.42
Total Debt to Equity0.00%

Cash Flow

Cash flow highlights the cash or cash equivalents moving in and out of a company during a particular period. It provides a clear picture of how well a company manages its cash by tracking its operating, investing and financing activities.

Particulars (in Cr)Mar 2026
Cash from Operating Activity523.23
Cash from Financing Activities-46.46
Cash from Investing Activities-582.29
Net Cash Flow-105.52
Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd.

CAPLIPOINT

Open Price

2,553.30

Prev Close

2,540.70

Upper Circuit

3,048.80

Lower Circuit

2,032.60

Volume

47,400

Average Traded Price

2,545.13
2,510.00Today's Low
2,597.90Today's High
1,500.3052W Low
2,699.0052W High

Historical Performance

1 DayNA
5 DaysNA
1 MonthNA
3 MonthsNA
1 YearNA
5 YearsNA
10 YearsNA
Trademarks owned by their respective owners are shown here only for ease of recall of the respective owner by public.